Angola

in page functions
[French]
Angola
Total population (2017) 26,655,481
Birth cohort (2017) 1,177,093
Surviving Infants (surviving to 1 year per year, 2017) 1,072,891
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 96/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 157/1000
Gross Nation Income (per capita US$, 2015) 4,180
Co-financing group (2018) Fully self-financing
No. of districts/territories (2016) 166

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Angola

Type of support

Approvals

2001-2022 (US$)
(28 Mar 2018)

Commitments

2001-2022 (US$)
(28 Mar 2018)

Disbursements

2000-2018 (US$)
(28 Mar 2018)

% Disbursed

(28 Mar 2018)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $114,706,904 $114,706,904 $114,341,090
Graduation grant (GG) $1,463,052 $1,463,052 $1,425,074 97%
Health system strengthening (HSS 1) $5,840,218 $5,840,218 $4,494,801 77%
Immunisation services support (ISS) $2,988,000 $2,988,000 $2,988,000 100%
Injection Safety Devices (NVS) $391,500 $391,500 $495,190 126%
Injection safety support (INS) $1,252,610 $1,252,610 $1,252,610 100%
IPV (NVS) $1,407,576 $1,407,576 $715,432 51%
MR-Catch-up campaign (NVS) $4,497,283 $4,497,283 $4,497,283 100%
Penta (NVS) $54,736,377 $54,736,377 $55,040,963 101%
Pneumo (NVS) $30,266,817 $30,266,817 $31,454,165 104%
Rotavirus (NVS) $8,119,578 $8,119,578 $8,233,679 101%
Vaccine Introduction Grant (VIG) $3,743,893 $3,743,893 $3,743,893 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Angola DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 80%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2007) 36.80%
Household survey: DTP3 coverage for female (2007) 38.40%
Household survey: Last DTP3 survey (2007) 38%
% districts achieving > 80% DTP3 coverage (2016) 54%
% districts achieving < 50% DTP3 coverage (2016) 11%
MCV WHO/UNICEF estimates (2016) 49%

Breakdown of support

Non-vaccine support Vaccine support
12% 88%
$13,904,378 $100,436,712

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Angola

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

30 November 2017

Gavi Board Dec 2017 - Nasala village visit

Millions of children set to be protected against typhoid fever

Gavi Board approves US$ 85 million funding window for 2019-2020 to support the introduction of typhoid conjugate vaccine in developing countries.

23 May 2017

Seth Q&A

Big Ideas: Gavi CEO Seth Berkley's Q&A, Part II

Ahead of Seth Berkley’s speech to the 2017 graduating class at Johns Hopkins University in Washington, DC on 23 June, Global Health published a two-part Q&A with the Gavi CEO. In this second article, Seth shares his concerns about the expansion of the vaccine hesitancy movement, explains why digital identity technologies in low- and middle-income countries can help improve vaccine coverage, and discusses the value of testing the potentially important malaria vaccine.

close icon

modal window here